Phibro Animal Health Corporation ( PAHC) - Stock Earnings
PAHC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
PAHC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 27.5 million USD | 373.9 million USD |
| 2026Q1 | 24.0 million USD | 383.5 million USD |
| 2026Q2 | 21.7 million USD | 396.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PAHC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 2.4 million USD | 1.0 billion USD |
| 2025 | 48.3 million USD | 1.3 billion USD |
| 2026 | 99.7 million USD | 1.5 billion USD |
| 2026 Est. | — | — |
PAHC
Price: $37.98
Dividend Yield: 1.29%
Forward Dividend Yield: 1.27%
Payout Ratio: 800.00%
Dividend Per Share: 0.48 USD
Earnings Per Share: 2.47 USD
P/E Ratio: 15.53
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 51500
Ebitda: 30.9 millionMarket Capitalization: 1.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR10: 2.00%